New Medical Affairs Function Focused on the Deep Scientific Communication with Investigators while Conducting Clinical Trials with Complex Protocol Design.
We offer an innovative solution for R&D Companies: a service of Investigator Science Liaisons (ISL) to support clinical development of new products in early stages (Clinical trials, phase II-III)